Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Mirabegron well tolerated and improves overactive bladder variables in large study

April 19, 2010

Clinical data disclosed on avosentan in overt diabetic nephropathy

April 14, 2010

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

April 8, 2010

Nymox outlines new plans for phase III BPH drug NX-1207

April 7, 2010

GSK's Duodart approved for benign prostatic hyperplasia in E.U.

April 6, 2010

Action Pharma completes dosing in phase II AP-214 trial

April 1, 2010

GLY-230 may ameliorate renal disease in patients with diabetes

April 1, 2010

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

March 24, 2010

Paricalcitol improves albuminuria in diabetic nephropathy

March 16, 2010

Bupivacaine alleviates bladder syndrome/interstitial cystitis pain in lidocaine-refractory patients

March 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...